Search research articles
Contact Us
Filters
Showing results (31-40 of 42) with videos related to
Page
of 5
Sort By:
European Journal of Haematology
|
April 3, 2004
Co-existence of Philadelphia chromosome positive acute megakaryoblastic and B-lymphoblastic mixed blast crisis of chronic myeloid leukemia with chronic lymphocytic leukemia
Simona Colla, Gabriella Sammarelli, Monica Crugnola, et al.
Blood
|
May 14, 2008
Constitutive expression of IL-12R beta 2 on human multiple myeloma cells delineates a novel therapeutic target
Irma Airoldi, Claudia Cocco, Nicola Giuliani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 2, 2003
Hematologic malignancies with extramedullary spread of disease. Case 1. Multiple myeloma with extramedullary involvement of the pleura and testes
Nicola Giuliani, Cecilia Caramatti, Giovanni Roti, et al.
Blood
|
June 28, 2008
Targeting MEK/MAPK signal transduction module potentiates ATO-induced apoptosis in multiple myeloma cells through multiple signaling pathways
Paolo Lunghi, Nicola Giuliani, Laura Mazzera, et al.
British Journal of Haematology
|
March 17, 2010
Randomized trial of two schedules of low-dose gemtuzumab ozogamicin as induction monotherapy for newly diagnosed acute myeloid leukaemia in older patients not considered candidates for intensive chemotherapy. A phase II study of the EORTC and GIMEMA leukaemia groups (AML-19)
Sergio Amadori, Stefan Suciu, Dominik Selleslag, et al.
Leukemia & Lymphoma
|
September 14, 2004
Fludarabine, cyclophosphamide and mitoxantrone for untreated follicular lymphoma: a report from the non-Hodgkin's lymphoma co-operative study group
Gino Santini, Teodoro Chisesi, Sandro Nati, et al.
Experimental Hematology
|
December 8, 2009
Distinct transcriptional profiles characterize bone microenvironment mesenchymal cells rather than osteoblasts in relationship with multiple myeloma bone disease
Katia Todoerti, Gina Lisignoli, Paola Storti, et al.
British Journal of Haematology
|
August 16, 2002
The post-transplant cytogenetic response to interferon is a major determinant of survival after autologous stem cell transplantation for chronic myeloid leukaemia in chronic phase
Eduardo Olavarria, Josy Reiffers, Concha Boque, et al.
Blood
|
September 13, 2007
The new tumor-suppressor gene inhibitor of growth family member 4 (ING4) regulates the production of proangiogenic molecules by myeloma cells and suppresses hypoxia-inducible factor-1 alpha (HIF-1alpha) activity: involvement in myeloma-induced angiogenesis
Simona Colla, Sara Tagliaferri, Francesca Morandi, et al.
Science Translational Medicine
|
October 15, 2011
Diabetes impairs hematopoietic stem cell mobilization by altering niche function
Francesca Ferraro, Stefania Lymperi, Simón Méndez-Ferrer, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 42) with videos related to
Sort By:
Page
of 5
European Journal of Haematology
|
April 3, 2004
Co-existence of Philadelphia chromosome positive acute megakaryoblastic and B-lymphoblastic mixed blast crisis of chronic myeloid leukemia with chronic lymphocytic leukemia
Simona Colla, Gabriella Sammarelli, Monica Crugnola, et al.
Blood
|
May 14, 2008
Constitutive expression of IL-12R beta 2 on human multiple myeloma cells delineates a novel therapeutic target
Irma Airoldi, Claudia Cocco, Nicola Giuliani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 2, 2003
Hematologic malignancies with extramedullary spread of disease. Case 1. Multiple myeloma with extramedullary involvement of the pleura and testes
Nicola Giuliani, Cecilia Caramatti, Giovanni Roti, et al.
Blood
|
June 28, 2008
Targeting MEK/MAPK signal transduction module potentiates ATO-induced apoptosis in multiple myeloma cells through multiple signaling pathways
Paolo Lunghi, Nicola Giuliani, Laura Mazzera, et al.
British Journal of Haematology
|
March 17, 2010
Randomized trial of two schedules of low-dose gemtuzumab ozogamicin as induction monotherapy for newly diagnosed acute myeloid leukaemia in older patients not considered candidates for intensive chemotherapy. A phase II study of the EORTC and GIMEMA leukaemia groups (AML-19)
Sergio Amadori, Stefan Suciu, Dominik Selleslag, et al.
Leukemia & Lymphoma
|
September 14, 2004
Fludarabine, cyclophosphamide and mitoxantrone for untreated follicular lymphoma: a report from the non-Hodgkin's lymphoma co-operative study group
Gino Santini, Teodoro Chisesi, Sandro Nati, et al.
Experimental Hematology
|
December 8, 2009
Distinct transcriptional profiles characterize bone microenvironment mesenchymal cells rather than osteoblasts in relationship with multiple myeloma bone disease
Katia Todoerti, Gina Lisignoli, Paola Storti, et al.
British Journal of Haematology
|
August 16, 2002
The post-transplant cytogenetic response to interferon is a major determinant of survival after autologous stem cell transplantation for chronic myeloid leukaemia in chronic phase
Eduardo Olavarria, Josy Reiffers, Concha Boque, et al.
Blood
|
September 13, 2007
The new tumor-suppressor gene inhibitor of growth family member 4 (ING4) regulates the production of proangiogenic molecules by myeloma cells and suppresses hypoxia-inducible factor-1 alpha (HIF-1alpha) activity: involvement in myeloma-induced angiogenesis
Simona Colla, Sara Tagliaferri, Francesca Morandi, et al.
Science Translational Medicine
|
October 15, 2011
Diabetes impairs hematopoietic stem cell mobilization by altering niche function
Francesca Ferraro, Stefania Lymperi, Simón Méndez-Ferrer, et al.
Page
of 5